Clinical Trials drug combinations - Archives

A New Drug to Target Cancer Cell Enzymes

In patients with metastatic pancreatic cancer, researchers are comparing FOLFIRINOX, the standard treatment, with FOLFIRINOX plus CPI-613, a new drug…

A latex-gloved hand doing close lab work

Targeting Cancer-Associated Wasting With Experimental Immunotherapy

Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.

black disc in motion against a yellow background

Electric Fields to Enhance Pancreatic Cancer Chemotherapy

A clinical trial uses electric fields to help slow the growth of tumor cells, In a clinical trial for pancreatic cancer patients.

Grayscale image of round lab containers with dark agar medium arranged in rows.

Finding a Safe Dose of a New Drug for Some Types of Solid Tumors

LMB-100 is a lab-created protein that targets mesothelin. It is being tested against pancreatic cancer and other solid tumors in a clinical trial.

Black and white photo of test tubes upright in a rack

Testing the Effectiveness of Immunotherapy Added to a New Drug Combination

Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.

metal balls connected with thin sticks on a purple and white background

Testing Immunotherapy for Safety Before and After Pancreatic Cancer Removal

Researchers are testing a new monoclonal antibody to see if it helps patients with pancreatic tumors that can be surgically removed.

Very high magnification of a pancreatic neuroendocrine tumor in a microscope

Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors

In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).

microscope slide of blue dots in a pink and white background that make up a gastric inflammatory fibroid polyp

Helping Some Types of Chemotherapy Penetrate Pancreatic Tumors

A clinical trial looks at the effectiveness of PEGPH20 in helping chemotherapy penetrate the stroma of pancreatic tumors, to make them removable.

Black and white image of a cancer cell from under a microscope

Immunotherapy for Pancreatic Neuroendocrine Tumors

Pancreatic neuroendocrine tumors (P-NETs) make up less than 5 percent of all pancreatic cancers. Unlike pancreatic ductal adenocarcinomas (PDAs), P-NETs…

microscope slide that looks like plant stems and flowers that are darker blue or yellow on a light blue background

Treating Tumors Before Pancreatic Cancer Surgery

Can neoadjuvant treatment such as chemoradiation make pancreatic cancer removal surgery more effective? That is the question asked by this clinical trial.